Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Compliance with guidelines for patients with bladder cancer: variation in the delivery of care.

Chamie K, Saigal CS, Lai J, Hanley JM, Setodji CM, Konety BR, Litwin MS; Urologic Diseases in America Project.

Cancer. 2011 Dec 1;117(23):5392-401. doi: 10.1002/cncr.26198. Epub 2011 Jul 11.

2.

Quality of care in patients with bladder cancer: a case report?

Chamie K, Saigal CS, Lai J, Hanley JM, Setodji CM, Konety BR, Litwin MS; Urologic Diseases in America Project.

Cancer. 2012 Mar 1;118(5):1412-21. doi: 10.1002/cncr.26402. Epub 2011 Aug 5.

3.

Adherence to surveillance among patients with superficial bladder cancer.

Schrag D, Hsieh LJ, Rabbani F, Bach PB, Herr H, Begg CB.

J Natl Cancer Inst. 2003 Apr 16;95(8):588-97.

4.

Use of radical cystectomy for patients with invasive bladder cancer.

Gore JL, Litwin MS, Lai J, Yano EM, Madison R, Setodji C, Adams JL, Saigal CS; Urologic Diseases in America Project.

J Natl Cancer Inst. 2010 Jun 2;102(11):802-11. doi: 10.1093/jnci/djq121. Epub 2010 Apr 16.

5.

Identifying better practices for early-stage bladder cancer.

Hollingsworth JM, Zhang YS, Miller DC, Skolarus TA, Wood DP, Lee CT, Montie JE, Hollenbeck BK.

Med Care. 2011 Dec;49(12):1112-7. doi: 10.1097/MLR.0b013e3182353baf.

PMID:
21979371
6.

Provider treatment intensity and outcomes for patients with early-stage bladder cancer.

Hollenbeck BK, Ye Z, Dunn RL, Montie JE, Birkmeyer JD.

J Natl Cancer Inst. 2009 Apr 15;101(8):571-80. doi: 10.1093/jnci/djp039. Epub 2009 Apr 7.

7.

Understanding the variation in treatment intensity among patients with early stage bladder cancer.

Hollingsworth JM, Zhang Y, Krein SL, Ye Z, Hollenbeck BK.

Cancer. 2010 Aug 1;116(15):3587-94. doi: 10.1002/cncr.25221.

8.

Predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project.

Huang GJ, Hamilton AS, Lo M, Stein JP, Penson DF.

J Urol. 2008 Aug;180(2):520-4; discussion 524. doi: 10.1016/j.juro.2008.04.016. Epub 2008 Jun 11.

9.

Adherence to surveillance guidelines after radical cystectomy: a population-based analysis.

Ehdaie B, Atoria CL, Lowrance WT, Herr HW, Bochner BH, Donat SM, Dalbagni G, Elkin EB.

Urol Oncol. 2014 Aug;32(6):779-84. doi: 10.1016/j.urolonc.2014.01.024. Epub 2014 Jun 13.

PMID:
24935876
10.

Reported use of intravesical therapy for non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Advocacy Network (BCAN) survey.

Nielsen ME, Smith AB, Pruthi RS, Guzzo TJ, Amiel G, Shore N, Lotan Y.

BJU Int. 2012 Oct;110(7):967-72. doi: 10.1111/j.1464-410X.2012.11060.x. Epub 2012 Apr 4.

11.
12.

Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.

Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T; Cancer Registration Committee of the Japanese Urological Association.

Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20.

13.

Management of high-risk non-muscle invasive bladder cancer.

Brausi M, Olaru V.

Minerva Urol Nefrol. 2012 Dec;64(4):255-60. Review.

PMID:
23288212
14.

Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer.

Lightfoot AJ, Rosevear HM, Nepple KG, O'Donnell MA.

Int J Urol. 2012 Nov;19(11):988-93. doi: 10.1111/j.1442-2042.2012.03089.x. Epub 2012 Jul 4.

16.

Understanding bladder cancer death: tumor biology versus physician practice.

Morris DS, Weizer AZ, Ye Z, Dunn RL, Montie JE, Hollenbeck BK.

Cancer. 2009 Mar 1;115(5):1011-20. doi: 10.1002/cncr.24136.

17.

Patterns of care for the treatment of bladder cancer.

Snyder C, Harlan L, Knopf K, Potosky A, Kaplan R.

J Urol. 2003 May;169(5):1697-701.

PMID:
12686811
18.

Breast cancer care compared with clinical Guidelines: an observational study in France.

Lebeau M, Mathoulin-Pélissier S, Bellera C, Tunon-de-Lara C, Daban A, Lipinski F, Jaubert D, Ingrand P, Migeot V; REPERES Group.

BMC Public Health. 2011 Jan 20;11:45. doi: 10.1186/1471-2458-11-45.

19.

A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group.

Brausi M, Witjes JA, Lamm D, Persad R, Palou J, Colombel M, Buckley R, Soloway M, Akaza H, Böhle A.

J Urol. 2011 Dec;186(6):2158-67. doi: 10.1016/j.juro.2011.07.076. Epub 2011 Oct 19. Review.

PMID:
22014799
20.

Diagnosis and management of superficial bladder cancer.

Amling CL.

Curr Probl Cancer. 2001 Jul-Aug;25(4):219-78. Review.

PMID:
11514784
Items per page

Supplemental Content

Write to the Help Desk